ID

25854

Beskrivning

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Montral Cognitive Assessment (MoCA)

Nyckelord

Versioner (1)
  1. 2017-09-21 2017-09-21 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

21 september 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

MoCA GSK study Chronic Coronary Heart Disease NCT00799903

Engelsk

MoCA GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulär  
MoCA General information
Beskrivning

MoCA General information

1. Date of visit/assessment
Beskrivning

Date of visit/assessment

Datatyp

date

Informed consent
Beskrivning

Informed consent

Datatyp

text

MoCA Eligibility Question
Beskrivning

MoCA Eligibility Question

1. Did subject meet all MoCA eligibility criteria?
Beskrivning

MoCA eligibility criteria met

Datatyp

text

[I51] 1. Availability of an approved translation
Beskrivning

Inclusion criterion

Datatyp

boolean

[I52] 2. Signed written informed consent prior to assessing the MoCA. Note: Consent to participate in the MoCA assessment is seperate from consent to participate in the parent study.
Beskrivning

Inclusion criterion

Datatyp

boolean

[E51] 1. Inability to complete all items on the MoCA due to physical limitation(s)
Beskrivning

Exclusion criterion

Datatyp

boolean

Montreal Cognitive Assessment
Beskrivning

Montreal Cognitive Assessment

MoCA Status
Beskrivning

MoCA Status

Datatyp

text

Montreal Cognitive Assessment (MoCA)
Beskrivning

Montreal Cognitive Assessment (MoCA)

Datatyp

text

Tillbaka till toppen

Similar models

MoCA GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
MoCA General information
Date of visit/assessment
Item
1. Date of visit/assessment
date
Informed consent
Item
Informed consent
text
Item Group
MoCA Eligibility Question
Item
1. Did subject meet all MoCA eligibility criteria?
text
MoCA eligibility criteria met
Code List
1. Did subject meet all MoCA eligibility criteria?
CL Item
Yes (Y)
CL Item
No, please select all boxes corresponding to the criteria that were not met (N)
Availability of an approved translation
Item
[I51] 1. Availability of an approved translation
boolean
informed consent
Item
[I52] 2. Signed written informed consent prior to assessing the MoCA. Note: Consent to participate in the MoCA assessment is seperate from consent to participate in the parent study.
boolean
physical limitation
Item
[E51] 1. Inability to complete all items on the MoCA due to physical limitation(s)
boolean
Item Group
Montreal Cognitive Assessment
MoCA Status
Item
MoCA Status
text
Montreal Cognitive Assessment (MoCA)
Item
Montreal Cognitive Assessment (MoCA)
text
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial